Animal Antimicrobials and Antibiotics Market Report to 2031

Spending on pet healthcare in the U.S. remains high. As per the American Pet Products Association (APPA), veterinary care is the second-highest source of expenditure.

SKU: PHA1113 Category: Therapeutic Drugs Tag: PHA1113 Code: PHA1113Pages: 320

Download Sample Form

"*" indicates required fields

Name*

Company*

Designation*

Job Title

Industry

Email*

Phone*

Address*

This field is hidden when viewing the form

Report Title

This field is hidden when viewing the form

Sample url

← Back to category Therapeutic Drugs

Description

Animal Antimicrobials and Antibiotics Market , our new study reveals trends, R&D progress, and predicted revenues
Where is the Animal Antimicrobials and Antibiotics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities, and business prospects there.

Discover how to stay ahead
500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Animal Antimicrobials and Antibiotics Market. See how to exploit opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles, and commercial developments.

Discover sales predictions for the world market and submarkets

Animal Antimicrobials and Antibiotics Market: By Product Type
• Penicillin
• Tetracycline
• Sulfonamides
• Quinolones
• Macrolides
• Cephalosporin
• Amingoglycoside
• Others

Animal Antimicrobials and Antibiotics Market: By Animal Type
• Companion animals
• Food-producing animals

Animal Antimicrobials and Antibiotics Market: By Mode of Delivery
• Oral powder or solutions
• Injections
• Premix
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa

The report also includes profiles and for some of the leading companies in the Animal Antimicrobials and Antibiotics Market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Animal Antimicrobials and Antibiotics Market will surpass million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Animal Antimicrobials and Antibiotics Market report helps you
In summary, our 500+ page report provides you with the following knowledge:

• Revenue forecasts to 2031 for Animal Antimicrobials and Antibiotics Market, with forecasts for Product Type, Animal Type, and Mode of Delivery, each forecasted at a global and regional level, discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2031 for 5 regional and 16 key national markets , See forecasts for the Animal Antimicrobials and Antibiotics market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted are the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market, including company profiles for 10 of the major companies involved in the Animal Antimicrobials and Antibiotics Market. Some of the companies profiled in this report include Elanco Animal Health, Zoetis Inc., Vetoquinol, Merck And Co. Inc., Boehringer Ingelheim, Ceva Sante Animale, Bayer AG, Novartis AG, Virbac SA, Eli Lilly And Company and Sanofi.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Animal Antimicrobials and Antibiotics Market Report to 2031: Forecasts By Product Type (Penicillin, Tetracycline, Sulfonamides, Quinolones, Macrolides, Cephalosporin, Amingoglycoside, and Others), By Animal Type (Companion Animals and Food-producing Animals), By Mode of Delivery (Oral powder or solutions, Injections, Premix, and Others) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed , order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Animal Antimicrobials and Antibiotics Market
2.1. Animal Antimicrobials and Antibiotics Market Definition
2.2. Product Type Submarkets Definitions
2.3. Animal Type Submarkets Definitions
2.4. Mode of Delivery Submarkets Definitions
3. Animal Antimicrobials and Antibiotics Market Overview
3.1. Global Animal Antimicrobials and Antibiotics Market Size and Forecast by Region
3.2. Global Animal Antimicrobials and Antibiotics Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising Demand for Animal-Derived Food Products
3.3.1.2. Increasing Incidence of Zoonotic Diseases
3.3.1.3. Implementation of Regulations for Preventing the Spread of Animal Diseases
3.3.1.4. Rising Demand for Pet Insurance and Growing Animal Health Expenditure
3.3.2. Market Restraints/Challenges
3.3.2.1. Dearth of New Antibiotics
3.3.2.2. Growing Resistance to Antimicrobials and Antibiotics
3.3.2.3. Routine Prophylactic Use of Antibiotics Being Replaced By Good Husbandry and Hygiene Practices
3.3.3. Opportunities
3.3.3.1. Untapped Emerging Markets
3.3.3.2. Growth in Companion Animal Population
3.3.4. Global Animal Antimicrobials and Antibiotics Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter's Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Animal Antimicrobials and Antibiotics Market Analysis and Forecast 2021-2031, by Product Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Penicillin
4.1.2. Tetracycline
4.1.3. Sulfonamides
4.1.4. Quinolones
4.1.5. Macrolides
4.1.6. Cephalosporin
4.1.7. Amingoglycoside
4.1.8. Others
5. Global Animal Antimicrobials and Antibiotics Market Analysis and Forecast, 2021-2031 by Animal Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Companion Animals
5.1.2. Food-producing Animals Iron Chelating Agents
6. Global Animal Antimicrobials and Antibiotics Market Analysis and Forecast, 2021-2031 by Mode of Delivery (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Oral powder or solutions
6.1.2. Injections
6.1.3. Premix
6.1.4. Others
7. North America Animal Antimicrobials and Antibiotics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Animal Antimicrobials and Antibiotics Market Size and Forecast by Product Type
7.3. North America Animal Antimicrobials and Antibiotics Market Size and Forecast by Animal Type
7.4. North America Animal Antimicrobials and Antibiotics Market Size and Forecast by Mode of Delivery
7.5. U.S. Animal Antimicrobials and Antibiotics Market
7.6. Canada Animal Antimicrobials and Antibiotics Market
8. Europe Animal Antimicrobials and Antibiotics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Animal Antimicrobials and Antibiotics Market Size and Forecast by Product Type
8.3. Europe Animal Antimicrobials and Antibiotics Market Size and Forecast by Animal Type
8.4. Europe Animal Antimicrobials and Antibiotics Market Size and Forecast by Mode of Delivery
8.5. UK Animal Antimicrobials and Antibiotics Market
8.6. Germany Animal Antimicrobials and Antibiotics Market
8.7. France Animal Antimicrobials and Antibiotics Market
8.8. Rest of Europe Animal Antimicrobials and Antibiotics Market
9. Asia Pacific Animal Antimicrobials and Antibiotics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Animal Antimicrobials and Antibiotics Market Size and Forecast by Product Type
9.3. Asia Pacific Animal Antimicrobials and Antibiotics Market Size and Forecast by Animal Type
9.4. Asia Pacific Animal Antimicrobials and Antibiotics Market Size and Forecast by Mode of Delivery
9.5. China Animal Antimicrobials and Antibiotics Market
9.6. India Animal Antimicrobials and Antibiotics Market
9.7. Japan Animal Antimicrobials and Antibiotics Market
9.8. Rest of Asia Pacific Animal Antimicrobials and Antibiotics Market
10. Latin America Animal Antimicrobials and Antibiotics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Animal Antimicrobials and Antibiotics Market Size and Forecast by Product Type
10.3. Latin America Animal Antimicrobials and Antibiotics Market Size and Forecast by Animal Type
10.4. Latin America Animal Antimicrobials and Antibiotics Market Size and Forecast by Mode of Delivery
10.4.1. Brazil Animal Antimicrobials and Antibiotics Market
10.4.2. Mexico Animal Antimicrobials and Antibiotics Market
10.4.3. Rest of Latin America Animal Antimicrobials and Antibiotics Market
11. MEA Animal Antimicrobials and Antibiotics Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Animal Antimicrobials and Antibiotics Market Size and Forecast by Product Type
11.3. MEA Animal Antimicrobials and Antibiotics Market Size and Forecast by Animal Type
11.4. MEA Animal Antimicrobials and Antibiotics Market Size and Forecast by Mode of Delivery
11.5. GCC Animal Antimicrobials and Antibiotics Market
11.6. South Africa Animal Antimicrobials and Antibiotics Market
11.7. Rest of MEA Animal Antimicrobials and Antibiotics Market
12. Companies in the Animal Antimicrobials and Antibiotics Market
12.1. Elanco Animal Health
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. Zoetis Inc.
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Vetoquinol
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Merck and Co. Inc.
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Boehringer Ingelheim
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. Ceva Sante Animale
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. Bayer AG
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. Novartis AG
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Virbac SA
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2019)
12.10. Eli Lilly and Company
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2019)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form

LIST OF TABLES
Table 1 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Animal Antimicrobials and Antibiotics Market Drivers & Restraints 2020
Table 7 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 13 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Penicillin ubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 43 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 44 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 45 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 46 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 47 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 48 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 49 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 50 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 51 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 52 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 53 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 54 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 55 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 56 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 57 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 58 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 59 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 60 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 72 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 73 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 74 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 75 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 76 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 77 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 78 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 79 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 80 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 81 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 82 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 83 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 84 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 85 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 86 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 87 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 88 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 89 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 90 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 91 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 115 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 149 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 150 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 155 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 171 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 237 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 238 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 239 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 240 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 241 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 242 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 243 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 244 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 245 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 246 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 247 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 248 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 249 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 250 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 251 Leading 10 Animal Antimicrobials and Antibiotics Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 252 Elanco Animal Health Profile 2019 (CEO, HQ, Founded, Website)
Table 253 Elanco Animal Health Animal Antimicrobials and Antibiotics Selected Recent Contracts 2019 (Date, Contract Product Type, Details)
Table 254 Elanco Animal Health Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 255 Zoetis Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 256 Zoetis Inc. Animal Antimicrobials and Antibiotics Selected Recent Contracts 2019 (Date, Contract Product Type, Details)
Table 257 Zoetis Inc. Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 258 Vetoquinol Profile 2019 (CEO, HQ, Founded, Website)
Table 259 Vetoquinol Animal Antimicrobials and Antibiotics Selected Recent Contracts 2017-2019 (Date, Contract Product Type, Details)
Table 260 Vetoquinol Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 261 Merck and Co. Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 262 Merck and Co. Inc. Animal Antimicrobials and Antibiotics Selected Recent Contracts 2015-2019 (Date, Contract Product Type, Details)
Table 263 Merck and Co. Inc. Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 264 Boehringer Ingelheim Profile 2019 (CEO, HQ, Founded, Website)
Table 265 Boehringer Ingelheim Animal Antimicrobials and Antibiotics Selected Recent Contracts 2015-2019 (Date, Contract Product Type, Details)
Table 266 Boehringer Ingelheim Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 267 Ceva Sante Animale Profile 2019 (CEO, HQ, Founded, Website)
Table 268 Ceva Sante Animale Animal Antimicrobials and Antibiotics Selected Recent Contracts 2015-2019 (Date, Contract Product Type, Details)
Table 269 Ceva Sante Animale Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 270 Bayer AG Profile 2019 (CEO, HQ, Founded, Website)
Table 271 Bayer AG Animal Antimicrobials and Antibiotics Selected Recent Contracts 2015-2019 (Date, Contract Product Type, Details)
Table 272 Bayer AG Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 273 Novartis AG Profile 2019 (CEO, HQ, Founded, Website)
Table 274 Novartis AG Animal Antimicrobials and Antibiotics Selected Recent Contracts 2015-2019 (Date, Contract Product Type, Details)
Table 275 Novartis AG Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 276 Virbac SA Profile 2019 (CEO, HQ, Founded, Website)
Table 277 Virbac SA Animal Antimicrobials and Antibiotics Selected Recent Contracts 2015-2019 (Date, Contract Product Type, Details)
Table 278 Virbac SA Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 279 Eli Lilly and Company Profile 2019 (CEO, HQ, Founded, Website)
Table 280 Eli Lilly and Company Animal Antimicrobials and Antibiotics Selected Recent Contracts 2015-2019 (Date, Contract Product Type, Details)
Table 281 Eli Lilly and Company Animal Antimicrobials and Antibiotics Product Offering (Segment, Product Offerings)
Table 282 Other Companies Involved in the Animal Antimicrobials and Antibiotics Market 2020 (Company, Location)

LIST OF FIGURES
Figure 1 Animal Antimicrobials and Antibiotics Market by Animal Type Overview
Figure 2 Animal Antimicrobials and Antibiotics Market by Product Type Overview
Figure 3 Animal Antimicrobials and Antibiotics Market by Mode of Delivery Overview
Figure 4 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 5 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 6 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 7 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 8 Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 9 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13 Animal Antimicrobials and Antibiotics Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 15 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17 Penicillin ubmarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18 Penicillin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Tetracycline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Quinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Cephalosporin Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 45 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 46 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 47 Amingoglycoside Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 48 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 49 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 50 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 51 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 52 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 53 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 54 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 55 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 56 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 57 Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 58 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 59 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 60 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 61 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 62 Companion Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 63 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 64 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 65 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 66 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 67 Food-producing Animals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 68 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 69 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 70 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 71 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 72 Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 73 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 74 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 75 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 76 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 77 Oral powder or solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 78 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 79 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 80 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 81 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 82 Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 83 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 84 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 85 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 86 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 87 Premix Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 88 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 89 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 90 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 91 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 92 Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 93 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 94 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 95 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 96 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 97 Regional Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 98 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 99 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 100 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 101 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 102 North America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 103 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 104 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 105 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 106 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 107 North America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 108 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 109 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 110 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 111 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 112 North America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 113 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 114 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 115 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 116 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 117 North America Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 118 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 119 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 120 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 121 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 122 US Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 123 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 124 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 125 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 126 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 127 Canada Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 128 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 129 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 130 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 131 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 132 Europe Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 133 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 134 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 135 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 136 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 137 Europe Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 138 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 139 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 140 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 141 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 142 Europe Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 143 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 144 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 145 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 146 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 147 Europe Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 148 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 149 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 150 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 151 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 152 UK Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 153 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 154 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 155 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 156 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 157 Germany Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 158 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 159 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 160 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 161 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 162 France Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 163 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 164 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 165 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 166 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 167 Rest of Europe Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 168 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 169 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 170 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 171 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 172 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 173 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 174 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 175 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 176 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 177 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 178 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 179 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 180 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 181 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 182 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 183 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 184 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 185 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 186 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 187 Asia Pacific Animal Antimicrobials and Antibiotics Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 188 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 189 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 190 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 191 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 192 China Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 193 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 194 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 195 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 196 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 197 India Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 198 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 199 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 200 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 201 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 202 Japan Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 203 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 204 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 205 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 206 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 207 RoAPAC Animal Antimicrobials and Antibiotics Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 208 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 209 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 210 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 211 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 212 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 213 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 214 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 215 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 216 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 217 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 218 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 219 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 220 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 221 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 222 Middle East Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 223 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 224 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 225 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 226 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 227 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 228 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 229 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 230 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 231 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 232 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 233 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 234 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 235 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 236 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 237 Latin America Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 238 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 239 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 240 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 241 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 242 Africa Animal Antimicrobials and Antibiotics Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 243 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 244 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 245 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 246 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 247 Africa Animal Antimicrobials and Antibiotics Market Forecast by Animal Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 248 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 249 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 250 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 251 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 252 Africa Animal Antimicrobials and Antibiotics Market Forecast by Mode of Delivery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)

Companies Profiled in the Report
1. Elanco Animal Health
2. Zoetis Inc.
3. Vetoquinol
4. Merck and Co. Inc.
5. Boehringer Ingelheim
6. Ceva Sante Animale
7. Bayer AG
8. Novartis AG
9. Virbac SA
10. Eli Lilly and Company
11. Sanofi

List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod

List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care